Table 1.
Comparison of the basic clinical and pathological characteristics of the patients (intention-to-treat population) in the study subgroups.
| Parameter | PFMT (n = 48) | AMT (n = 47) | DMT (n = 48) | P |
|---|---|---|---|---|
| Age (year) [mean (SD)] | 63.6 (6.1) | 64.4 (5.1) | 64.3 (4.8) | 0.13 |
| PSA (ng/ml) [mean (SD)] | 6.8 (4.3) | 7.1 (3.3) | 6.3 (3.1) | 0.53 |
| Prostate volume (ml) [mean (SD)] | 40.8 (14.4) | 40.6 (13.6) | 41.3 (14.1) | 0.71 |
| Body mass index [mean (SD)] | 28.0 (4.2) | 28.1 (3.9) | 28.3 (4.0) | 0.84 |
| Pathological stage [n (%)] | ||||
|
pT2 pT3a pT3b |
30 (62.5) 14 (29.2) 4 (8.3) |
30 (63.8) 15 (32) 2 (4.2) |
31 (66) 16 (34) — |
0.28 |
| Pathological GS [n (%)] | ||||
|
6 7 8–10 |
9 (18.8) 35 (72.9) 4 (8.3) |
10 (21.3) 35 (74.5) 2 (4.2) |
11 (23.4) 35 (74.5) 1 (2.1) |
0.13 |
| Baseline PFMS [mean (SD)] | 91.5 (13.8) | 92.1 (10.5) | 90.8 (13.1) | 0.87 |
| Baseline PFME [mean (SD)] | 8.0 (2.7) | 7.9 (2.4) | 7.9 (2.7) | 0.88 |
| UI after catheter removal (g) [mean (SD)] | 308.4 (114.6) | 303 (91.9) | 296.2 (115.2) | 0.83 |
PFMT pelvic floor muscle training group, AMT abdominal muscle training group, DMT diaphragm muscle training group, SD standard deviation, PSA prostate-specific antigen, GS Gleason score, PFMS pelvic floor muscles strength, PFME pelvic floor muscles endurance, UI urinary incontinence.